Answers are grounded in this paper and cite their sources.
thrombotic mechanism, and new cytopenias should prompt evaluation for hypersplenism before assuming marrow failure [1].Whether the co-occurrence with CVID is coincidental remains unclear, but the practical message stands: in PNH, a patent macrovasculature does not equate to the absence of thrombosis.
No takes yet. Share an insight, caveat, or question.
Kural et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: